Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

News Focus

Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > American Society of Echocardiography

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Apr 16, 2024 7:03pm

59 Views

Post# 35992657

American Society of Echocardiography

Mushroom-shaped right ventricular outflow tract (ms-RVOT) aneurysms may provide an early clue for the diagnosis of pediatric arrhythmogenic right ventricular cardiomyopathy (ARVC). #echofirst

Mushroom-Shaped Right Ventricular Outflow Tract Aneurysm May Provide an Early Clue in Pediatric Arrhythmogenic Right Ventricular Cardiomyopathy

cvcasejournal.com • 7 min read

Conclusion

Pediatric-onset ARVC may be suspected in early stages before progression to definite ARVC by the qualitative finding of an ms-RVOT. This finding may serve as an early clue that may raise caution and urge closer monitoring of these patients, even in the absence of symptoms or family history. This finding has not been previously reported in children or young adults. Its presence may trigger preemptive management strategies, including close monitoring to prevent SCD.

<< Previous

Bullboard Posts

Next >>

Hempalta acquires controlling interest in Hemp Carbon Standard